MANILA (REUTERS) – Philippine senators on Friday (Jan 15) questioned the government’s preference for the Chinese Covid-19 vaccine after latest data showed it has a lower efficacy rate, saying this would not bode well for a country seeking to boost confidence in vaccines.…<\/p>\n
The post Philippine senators query government's preference for China Covid-19 vaccine after new efficacy data<\/a> appeared first on ChinaPulse.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" MANILA (REUTERS) \u2013 Philippine senators on Friday (Jan 15) questioned the government\u2019s preference for the Chinese Covid-19 vaccine after latest data showed it has a lower efficacy rate, saying this would not bode well for a country seeking to boost confidence in vaccines.\u2026<\/p>\n The post Philippine senators query government's preference for China Covid-19 vaccine after new efficacy data<\/a> appeared first on ChinaPulse.com<\/a>.<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65,144,213,194,249,1542,484],"tags":[7582,2636,3472,10323,10324,10449,3942,10450,10328,10329,1977,7035],"class_list":["post-68837","post","type-post","status-publish","format-standard","hentry","category-beijing","category-china","category-china-news","category-news-chinese-law","category-russia","category-technology","category-united-states","tag-biotech","tag-brazil","tag-chinese","tag-coronavirus","tag-covid-19","tag-duterte","tag-europe","tag-manila","tag-pandemic","tag-philippines","tag-senate","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/68837"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=68837"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/68837\/revisions"}],"predecessor-version":[{"id":68838,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/68837\/revisions\/68838"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=68837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=68837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=68837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}